C WorldWide Group’s Acorda Therapeutics ACOR Stock Holding History

C WorldWide Group’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-42	Closed	-$106K	–	137
2017 Q1	$106K	Buy	+42	New	+$121K	﹤0.01%	127
2016 Q3	–	Sell	-83	Closed	-$255K	–	129
2016 Q2	$255K	Hold	83	–	–	﹤0.01%	111
2016 Q1	$264K	Hold	83	–	–	0.01%	117
2015 Q4	$428K	Sell	83 -53	-39%	-$232K	0.01%	126
2015 Q3	$432K	Buy	136 +3	+2%	+$11.6K	0.01%	127
2015 Q2	$533K	Hold	133	–	–	0.01%	125
2015 Q1	$532K	Hold	133	–	–	0.01%	97
2014 Q4	$654K	Buy	+133	New	+$571K	0.01%	91

Other funds holding ACOR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

C WorldWide Group's ACOR Position: Q2 2017 in Review

C WorldWide Group sold out of Acorda Therapeutics (ACOR) in Q2 2017, closing a stake of 42 shares — an estimated $106K sold.

C WorldWide Group first reported a position in ACOR in Q4 2014 and held it in 8 quarters. The position peaked at $654K in Q4 2014. 151 funds tracked by Wall St. Rank hold ACOR as of Q2 2017.

C WorldWide Group reported no remaining Acorda Therapeutics position as of Q2 2017 after selling out during the quarter.
C WorldWide Group sold 42 Acorda Therapeutics shares in Q2 2017, an estimated $106K.
C WorldWide Group first reported a position in Acorda Therapeutics in Q4 2014 and held it in 8 quarters.
C WorldWide Group's Acorda Therapeutics position peaked at $654K in Q4 2014.
151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2017.

Based on C WorldWide Group's 13F filing for Q2 2017, filed 2 Aug 2017.